STX-241

STX-241 · Pierre Fabre Medicament

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for STX-241, covering 2025-09-17 to 2025-09-17. Get the full timeline:

Most recent: Clinical Trial Update: Study of FIH of STX-241 in Locally Advanced or Metastatic NSCLC Resistant to EGFR TKIs [Phase 1, Phase 2]